This manuscript describing the phenotypes associated with loss and gain of RVCL-S documents important findings that have practical implications. Although the data and methods are solid and support ...

New software evolves from VRS utility to compliance-as-a-service platform for pharmaceutical manufacturers, wholesalers, pharmacies.

The Centers for Medicare & Medicaid Services intends to impose sanctions that would suspend enrollment ​in Elevance Health's Medicare Advantage prescription drug plans starting March 31, pushing ‌the ...

New release adds global database connections, logical datasources, relational validation and flexible inspections to ...

FDA's Plausible Mechanism Framework streamlines individualized therapy approvals for ultra-rare diseases.

Following surveillance operations, the Nghe An provincial Public Security Force’s Drug Crime Investigation Division ...

Modern driver qualification file platform offers automated compliance tracking, one-click audit reports, at an ...

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

After the FDA's surprise refusal to take up a review of Moderna's next-gen flu vaccine, the public disagreement between U.S. regulators and the mRNA specialist took a new turn Wednesday, with the U.S.

Moderna (MRNA) Tuesday said that the U.S. Food and Drug Administration will not initiate a review of the biologics license application for its investigational influenza vaccine, mRNA-1010, and has ...

After crackdown threats from the FDA, Hims & Hers quickly pulled its copycat Wegovy pill, a cheaper compounded form of semaglutide. Compounded drugs are not FDA-approved and don’t go through the same ...

During the first year of the Trump administration, signs of an anti-mRNA slant within the FDA and the Department of Health and Human Services (HHS) became more and more evident. Now, with a refusal-to ...